Disease mechanisms and emerging therapies: protein kinases and their inhibitors in myocardial disease
Authors:
- 1 August 2006
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Cardiovascular Medicine
- Vol. 3 (8) , 437-445
Abstract
Most clinically validated drugs for treating patients with cardiovascular disease target G-protein-coupled receptors (GPCRs) in the cell membrane. GPCRs engage and activate multiple intracellular signaling cascades, which are regulated by serine/threonine protein kinases. These protein kinases are cytoplasmic, more abundant than GPCRs, and have rapidly emerged as drug targets in cardiovascular diseases. One exciting potential advantage to targeting serine/threonine protein kinases rather than GPCRs is the capability of influencing more precisely the diverse biological responses that are initiated by a common GPCR. On the other hand, highly specific targeting of individual protein kinases for drug therapy presents some medicinal chemistry challenges. This concise review focuses on the biology of serine/threonine protein kinases in the cardiovascular system, discusses the current state of protein kinase inhibitor drug development for myocardial diseases, and illustrates some of the unique medicinal chemistry considerations in targeting protein kinases.Keywords
This publication has 43 references indexed in Scilit:
- Beyond beta blockersNature Medicine, 2005
- Calmodulin kinase II inhibition protects against structural heart diseaseNature Medicine, 2005
- Kinomics: methods for deciphering the kinomeNature Methods, 2004
- Inhibitors of Protein Kinase Signaling PathwaysCirculation, 2004
- Differential Regulation of the Cardiac Sodium Calcium Exchanger Promoter in Adult and Neonatal Cardiomyocytes by Nkx2.5 and Serum Response FactorJournal of Molecular and Cellular Cardiology, 2002
- Protein kinases — the major drug targets of the twenty-first century?Nature Reviews Drug Discovery, 2002
- Identification of a Gene Responsible for Familial Wolff–Parkinson–White SyndromeNew England Journal of Medicine, 2001
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001
- A Calcineurin-Dependent Transcriptional Pathway for Cardiac HypertrophyCell, 1998
- Sensitivity of CaM Kinase II to the Frequency of Ca 2+ OscillationsScience, 1998